Synaptogenix, Inc. received a notice from Nasdaq stating that its common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2), but the notice has no immediate effect on the listing or trading of the stock.